{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:24:20Z","timestamp":1776270260466,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"35","license":[{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2016,9,1]]},"DOI":"10.1038\/onc.2015.527","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T11:16:49Z","timestamp":1453720609000},"page":"4633-4640","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["WASF3 provides the conduit to facilitate invasion and metastasis in breast cancer cells through HER2\/HER3 signaling"],"prefix":"10.1038","volume":"35","author":[{"given":"Y","family":"Teng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Pi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J K","family":"Cowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"key":"BFonc2015527_CR1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrc3125","volume":"11","author":"N Sethi","year":"2011","unstructured":"Sethi N, Kang Y . Unravelling the complexity of metastasis-molecular understanding and targeted therapies. Nat Rev Cancer 2011; 11: 735\u2013748.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2015527_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA . Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147: 275\u2013292.","journal-title":"Cell"},{"key":"BFonc2015527_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrg2101","volume":"8","author":"DX Nguyen","year":"2007","unstructured":"Nguyen DX, Massagu\u00e9 J . Genetic determinants of cancer metastasis. Nat Rev Genet 2007; 8: 341\u2013352.","journal-title":"Nat Rev Genet"},{"key":"BFonc2015527_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc1360","volume":"4","author":"A Gschwind","year":"2004","unstructured":"Gschwind A, Fischer OM, Ullrich A . The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat Rev Cancer 2004; 4: 361\u2013370.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2015527_CR5","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1158\/0008-5472.CAN-04-3388","volume":"65","author":"C M\u00fcller-Tidow","year":"2005","unstructured":"M\u00fcller-Tidow C, Diederichs S, Bulk E, Pohle T, Steffen B, Schw\u00e4ble J et al. Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. Cancer Res 2005; 65: 1778\u20131782.","journal-title":"Cancer Res"},{"key":"BFonc2015527_CR6","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1200\/JCO.2003.01.504","volume":"21","author":"J Mendelsohn","year":"2003","unstructured":"Mendelsohn J, Baselga J . Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 2003; 21: 2787\u20132799.","journal-title":"J Clin Oncol"},{"key":"BFonc2015527_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrc2656","volume":"9","author":"J Baselga","year":"2009","unstructured":"Baselga J, Swain SM . Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 2009; 9: 463\u2013475.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2015527_CR8","first-page":"3107","volume":"30","author":"H Tsujioka","year":"2010","unstructured":"Tsujioka H, Yotsumoto F, Shirota K, Horiuchi S, Yoshizato T, Kuroki M et al. Emerging strategies for ErbB ligand-based targeted therapy for cancer. Anticancer Res 2010; 30: 3107\u20133112.","journal-title":"Anticancer Res"},{"key":"BFonc2015527_CR9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1158\/1055-9965.EPI-08-1101","volume":"18","author":"RE Roses","year":"2009","unstructured":"Roses RE, Paulson EC, Sharma A, Schueller JE, Nisenbaum H, Weinstein S et al. HER-2\/neu overexpression as a predictor for the transition from in situ to invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 1386\u20131389.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFonc2015527_CR10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1056\/NEJM198811103191902","volume":"319","author":"MJ van de Vijver","year":"1988","unstructured":"van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O et al. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 1988; 319: 1239\u20131245.","journal-title":"N Engl J Med"},{"key":"BFonc2015527_CR11","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol 2010; 28: 3271\u20133277.","journal-title":"J Clin Oncol"},{"key":"BFonc2015527_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexmp.2009.05.001","volume":"87","author":"JA Freudenberg","year":"2009","unstructured":"Freudenberg JA, Wang Q, Katsumata M, Drebin J, Nagatomo I, Greene MI . The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies. Exp Mol Pathol 2009; 87: 1\u201311.","journal-title":"Exp Mol Pathol"},{"key":"BFonc2015527_CR13","doi-asserted-by":"publisher","first-page":"29491","DOI":"10.1074\/jbc.M110.136770","volume":"285","author":"E Johnson","year":"2010","unstructured":"Johnson E, Seachrist DD, DeLeon-Rodriguez CM, Lozada KL, Miedler J, Abdul-Karim FW et al. HER2\/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42. J Biol Chem 2010; 285: 29491\u201329501.","journal-title":"J Biol Chem"},{"key":"BFonc2015527_CR14","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1158\/0008-5472.CAN-08-0380","volume":"68","author":"ST Lee-Hoeflich","year":"2008","unstructured":"Lee-Hoeflich ST, Crocker L, Yao E, Pham T, Munroe X, Hoeflich KP et al. A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy. Cancer Res 2008; 68: 5878\u20135887.","journal-title":"Cancer Res"},{"key":"BFonc2015527_CR15","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1158\/0008-5472.CAN-11-3594","volume":"72","author":"DB Vaught","year":"2012","unstructured":"Vaught DB, Stanford JC, Young C, Hicks DJ, Wheeler F, Rinehart C et al. HER3 is required for HER2-induced preneoplastic changes to the breast epithelium and tumor formation. Cancer Res 2012; 72: 2672\u20132682.","journal-title":"Cancer Res"},{"key":"BFonc2015527_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1165\/rcmb.4850","volume":"27","author":"J Liu","year":"2002","unstructured":"Liu J, Kern JA . Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation. Am J Respir Cell Mol Biol 2002; 27: 306\u2013313.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFonc2015527_CR17","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1529\/biophysj.105.080580","volume":"90","author":"H Shankaran","year":"2006","unstructured":"Shankaran H, Wiley HS, Resat H . Modeling the effects of HER\/ErbB1-3 coexpression on receptor dimerization and biological response. Biophys J 2006; 90: 3993\u20134009.","journal-title":"Biophys J"},{"key":"BFonc2015527_CR18","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1038\/sj.onc.1204820","volume":"20","author":"DG Bosc","year":"2001","unstructured":"Bosc DG, Goueli BS, Janknecht R . HER2\/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene 2001; 20: 6215\u20136224.","journal-title":"Oncogene"},{"key":"BFonc2015527_CR19","doi-asserted-by":"publisher","first-page":"7621","DOI":"10.1158\/1078-0432.CCR-04-1061","volume":"10","author":"JM Pellikainen","year":"2004","unstructured":"Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM . Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin Cancer Res 2004; 10: 7621\u20137628.","journal-title":"Clin Cancer Res"},{"key":"BFonc2015527_CR20","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1038\/sj.onc.1205734","volume":"21","author":"K Sossey-Alaoui","year":"2002","unstructured":"Sossey-Alaoui K, Su G, Malaj E, Roe B, Cowell JK . WAVE3, an actin-polymerization gene, is truncated and inactivated as a result of a constitutional t(1;13)(q21;q12) chromosome translocation in a patient with ganglioneuroblastoma. Oncogene 2002; 21: 5967\u20135974.","journal-title":"Oncogene"},{"key":"BFonc2015527_CR21","first-page":"287","volume":"24","author":"K Sossey-Alaoui","year":"2013","unstructured":"Sossey-Alaoui K . Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasis. Semin Cell Dev Biol 2013; 24: 287\u2013297.","journal-title":"Semin Cell Dev Biol"},{"key":"BFonc2015527_CR22","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010; 12: R68.","journal-title":"Breast Cancer Res"},{"key":"BFonc2015527_CR23","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1002\/ijc.25964","volume":"129","author":"Y Teng","year":"2011","unstructured":"Teng Y, Liu M, Cowell JK . Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells. Int J Cancer 2011; 129: 2825\u20132835.","journal-title":"Int J Cancer"},{"key":"BFonc2015527_CR24","doi-asserted-by":"publisher","first-page":"E905","DOI":"10.1002\/ijc.27631","volume":"131","author":"P Ghoshal","year":"2012","unstructured":"Ghoshal P, Teng Y, Lesoon L, Cowell JK . HIF1A induces expression of the WASF3 metastasis associated gene under hypoxic conditions. Int J Cancer 2012; 131: E905\u2013E915.","journal-title":"Int J Cancer"},{"key":"BFonc2015527_CR25","doi-asserted-by":"publisher","first-page":"10051","DOI":"10.1074\/jbc.M111.335000","volume":"287","author":"Y Teng","year":"2012","unstructured":"Teng Y, Ngoka L, Mei Y, Lesoon L, Cowell JK . HSP90 and HSP70 are essential for stabilization and activation of the WASF3 metastasis promoting protein. J Biol Chem 2012; 287: 10051\u201310059.","journal-title":"J Biol Chem"},{"key":"BFonc2015527_CR26","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1093\/carcin\/bgt167","volume":"4","author":"Y Teng","year":"2013","unstructured":"Teng Y, Ghoshal P, Ngoka L, Mei Y, Cowell JK . Critical role of the WASF3 gene in JAK2\/STAT3 regulation of cancer cell invasion. Carcinogenesis 2013; 4: 1994\u20131999.","journal-title":"Carcinogenesis"},{"key":"BFonc2015527_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/1471-2407-13-453","volume":"13","author":"Y Teng","year":"2013","unstructured":"Teng Y, Xie X, Walker S, White DT, Mumm JS, Cowell JK . Evaluating human cancer cell metastasis in zebrafish. BMC Cancer 2013; 13: 453.","journal-title":"BMC Cancer"},{"key":"BFonc2015527_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/onc.2012.565","volume":"33","author":"Y Teng","year":"2014","unstructured":"Teng Y, Mei Y, Hawthorn LA, Cowell JK . WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells. Oncogene 2014; 33: 203\u2013211.","journal-title":"Oncogene"},{"key":"BFonc2015527_CR29","first-page":"e28086","volume":"3","author":"Y Teng","year":"2014","unstructured":"Teng Y, Ross JL, Cowell JK . The involvement of JAK-STAT3 in cell motility, invasion, and metastasis. JAKSTAT 2014; 3: e28086.","journal-title":"JAKSTAT"},{"issue":"3","key":"BFonc2015527_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/onc.2015.86","volume":"35","author":"Y Teng","year":"2015","unstructured":"Teng Y, Ren X, Li H, Shull A, Kim J, Cowell JK . Mitochondrial ATAD3A combines with GRP78 to regulate the WASF3 metastasis-promoting protein. Oncogene 2015, e-pub ahead of print 30 March 2015; doi:10.1038\/onc.2015.86.","journal-title":"Oncogene"},{"key":"BFonc2015527_CR31","doi-asserted-by":"publisher","first-page":"21748","DOI":"10.1074\/jbc.M500503200","volume":"280","author":"K Sossey-Alaoui","year":"2005","unstructured":"Sossey-Alaoui K, Li X, Ranalli TA, Cowell JK . WAVE3-mediated cell migration and lamellipodia formation are regulated downstream of phosphatidylinositol 3-kinase. J Biol Chem 2005; 280: 21748\u201321755.","journal-title":"J Biol Chem"},{"key":"BFonc2015527_CR32","doi-asserted-by":"publisher","first-page":"26257","DOI":"10.1074\/jbc.M701484200","volume":"282","author":"K Sossey-Alaoui","year":"2007","unstructured":"Sossey-Alaoui K, Li X, Cowell JK . c-Abl-mediated phosphorylation of WAVE3 is required for lamellipodia formation and cell migration. J Biol Chem 2007; 282: 26257\u201326265.","journal-title":"J Biol Chem"},{"key":"BFonc2015527_CR33","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/annonc\/mdg365","volume":"14","author":"G Atalay","year":"2003","unstructured":"Atalay G, Cardoso F, Awada A, Piccart MJ . Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer. Ann Oncol 2003; 14: 1346\u20131363.","journal-title":"Ann Oncol"},{"key":"BFonc2015527_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1158\/1078-0432.CCR-11-0072","volume":"17","author":"S Modi","year":"2011","unstructured":"Modi S, Stopeck A, Linden H, Solit D, Chandarlapaty S, Rosen N et al. HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab. Clin Cancer Res 2011; 17: 132\u2013139.","journal-title":"Clin Cancer Res"},{"key":"BFonc2015527_CR35","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/sj.onc.1205184","volume":"21","author":"AD Basso","year":"2002","unstructured":"Basso AD, Solit DB, Munster PN, Rosen N . Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2. Oncogene 2002; 21: 1159\u20131166.","journal-title":"Oncogene"},{"key":"BFonc2015527_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/bcr3621","volume":"16","author":"M Barok","year":"2014","unstructured":"Barok M, Joensuu H, Isola J . Trastuzumab emtansine: mechanisms of action and drug resistance. Breast Cancer Res 2014; 16: 209.","journal-title":"Breast Cancer Res"},{"key":"BFonc2015527_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2014.05.019","volume":"351","author":"C Gomez-Mart\u00edn","year":"2014","unstructured":"Gomez-Mart\u00edn C, Lopez-Rios F, Aparicio J, Barriuso J, Garc\u00eda-Carbonero R, Pazo R et al. A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond. Cancer Lett 2014; 351: 30\u201340.","journal-title":"Cancer Lett"},{"key":"BFonc2015527_CR38","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/sj.bjc.6605850","volume":"103","author":"Y Teng","year":"2010","unstructured":"Teng Y, Ren M, Cheney R, Sharma S, Cowell JK . Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases. Br J Cancer 2010; 103: 1066\u20131075.","journal-title":"Br J Cancer"},{"key":"BFonc2015527_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10549-013-2753-1","volume":"142","author":"MA Taylor","year":"2013","unstructured":"Taylor MA, Davuluri G, Parvani JG, Schiemann BJ, Wendt MK, Plow EF et al. Upregulated WAVE3 expression is essential for TGF-\u03b2-mediated EMT and metastasis of triple-negative breast cancer cells. Breast Cancer Res Treat 2013; 142: 341\u2013353.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2015527_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrm2069","volume":"8","author":"T Takenawa","year":"2007","unstructured":"Takenawa T, Suetsugu S . The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat Rev Mol Cell Biol 2007; 8: 37\u201348.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2015527_CR41","doi-asserted-by":"crossref","unstructured":"Teng Y, Bahassan A, Dong DY, Hanold LE, Ren X, Kennedy EJ et al. Targeting the WASF3-CYFIP1 complex using stapled peptides suppresses cancer cell invasion. Cancer Res 2015, e-pub ahead of print 16 December 2015.","DOI":"10.1158\/0008-5472.CAN-15-1680"},{"key":"BFonc2015527_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ygyno.2013.05.005","volume":"130","author":"J Zhang","year":"2013","unstructured":"Zhang J, Zhou S, Tang L, Shen L, Xiao L, Duan Z et al. WAVE1 gene silencing via RNA interference reduces ovarian cancer cell invasion, migration and proliferation. Gynecol Oncol 2013; 130: 354\u2013361.","journal-title":"Gynecol Oncol"},{"key":"BFonc2015527_CR43","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1038\/onc.2008.13","volume":"27","author":"Z Cai","year":"2008","unstructured":"Cai Z, Zhang G, Zhou Z, Bembas K, Drebin JA, Greene MI et al. Differential binding patterns of monoclonal antibody 2C4 to the ErbB3-p185her2\/neu and the EGFR-p185her2\/neu complexes. Oncogene 2008; 27: 3870\u20133874.","journal-title":"Oncogene"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2015527.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2015527","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2015527.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:27:17Z","timestamp":1647894437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2015527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":43,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2016,9,1]]}},"alternative-id":["BFonc2015527"],"URL":"https:\/\/doi.org\/10.1038\/onc.2015.527","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]},"assertion":[{"value":"7 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}